HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wolf H Fridman Selected Research
Wolf H Fridman Research Topics
Disease
39
Neoplasms (Cancer)
01/2022 - 03/2002
6
Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 11/2010
4
Inflammation (Inflammations)
01/2022 - 07/2007
4
Melanoma (Melanoma, Malignant)
12/2019 - 11/2002
3
Tertiary Lymphoid Structures
10/2021 - 01/2019
3
Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 04/2006
3
Head and Neck Neoplasms (Head and Neck Cancer)
01/2013 - 05/2008
2
Kidney Neoplasms (Kidney Cancer)
01/2021 - 11/2010
2
Lung Neoplasms (Lung Cancer)
01/2021 - 02/2013
2
Microsatellite Instability
01/2020 - 11/2017
2
Neoplasm Metastasis (Metastasis)
01/2011 - 11/2002
2
Atypical Hemolytic Uremic Syndrome
09/2009 - 12/2008
2
Lymphoma (Lymphomas)
09/2007 - 04/2006
2
Infections
05/2007 - 06/2005
1
Hypoxia (Hypoxemia)
01/2021
1
Alzheimer Disease (Alzheimer's Disease)
10/2020
1
Sarcoma (Soft Tissue Sarcoma)
01/2020
1
Carcinoma (Carcinomatosis)
01/2019
1
Colonic Neoplasms (Colon Cancer)
11/2017
1
Disease Progression
08/2017
1
Prostatic Neoplasms (Prostate Cancer)
10/2011
1
Testicular Neoplasms (Testicular Cancer)
01/2008
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2007
1
Complement Component 7 Deficiency
05/2007
1
Breast Neoplasms (Breast Cancer)
04/2006
1
Virus Diseases (Viral Diseases)
06/2005
1
Sezary Syndrome (Sezary Erythroderma)
10/2004
1
Mycosis Fungoides
10/2004
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2004
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2002
Drug/Important Bio-Agent (IBA)
9
Complement System Proteins (Complement)
IBA
01/2022 - 05/2007
7
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2013
6
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2013
4
Immunoglobulin G (IgG)
IBA
01/2022 - 11/2002
4
Cancer Vaccines
IBA
02/2013 - 01/2008
4
Cytokines
IBA
05/2008 - 03/2002
3
Biological Products
IBA
01/2021 - 03/2002
2
Antibodies
IBA
01/2022 - 01/2021
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2021
2
Immunologic Factors (Immunomodulators)
IBA
11/2017 - 10/2011
2
Antigens
IBA
12/2014 - 01/2008
2
Monoclonal Antibodies
IBA
12/2014 - 04/2006
2
Vaccines
IBA
02/2013 - 09/2007
2
Interleukin-15 (Interleukin 15)
IBA
01/2011 - 05/2008
2
Interleukin-15 Receptors (Interleukin 15 Receptor)
IBA
01/2011 - 05/2008
2
Chemokines
IBA
01/2011 - 09/2007
2
Neoplasm Antibodies
IBA
12/2008 - 11/2002
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2008 - 06/2005
2
Interleukin-10 (Interleukin 10)
IBA
07/2007 - 06/2005
2
Interleukin-17 (Interleukin 17)
IBA
10/2004 - 03/2002
1
Anaphylatoxins
IBA
01/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2021
1
Complement C1s (C1 Esterase)
IBA
01/2021
1
Enzymes
IBA
01/2021
1
Complement Factor H (Factor H)
IBA
01/2021
1
Paraffin
IBA
01/2021
1
Ipilimumab
IBA
12/2019
1
guadecitabine
IBA
12/2019
1
dehydroacetic acid (DHAS)
IBA
12/2019
1
DNA (Deoxyribonucleic Acid)
IBA
12/2019
1
Immune Checkpoint Proteins
IBA
01/2019
1
Complement C1q (C1q Complement)
IBA
01/2019
1
Complement C5a (Complement 5a)
IBA
01/2019
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
08/2017
1
Messenger RNA (mRNA)
IBA
08/2017
1
Pharmaceutical Preparations
IBA
12/2014
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2011
1
Sunitinib (Sutent)
FDA Link
11/2010
1
Complement C3-C5 Convertases (C3 Convertase)
IBA
09/2009
1
Complement C3 (C3 Complement)
IBA
12/2008
1
Fc gamma receptor IIB
IBA
12/2008
1
Protein Isoforms (Isoforms)
IBA
12/2008
1
ADAM17 Protein
IBA
05/2008
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2008
1
Perforin
IBA
01/2008
1
B-Cell Activating Factor
IBA
09/2007
1
Interleukin-2 (IL2)
IBA
09/2007
1
alpha-galactosylceramide
IBA
09/2007
1
Macrophage Colony-Stimulating Factor
IBA
07/2007
1
Complement C7 (Complement 7)
IBA
05/2007
1
Neoplasm Antigens (Tumor Antigens)
IBA
06/2005
1
Antiviral Agents (Antivirals)
IBA
06/2005
1
Gangliosides
IBA
11/2002
1
IgG Receptors (Fc gamma RI)
IBA
11/2002
1
Antigen-Antibody Complex (Immune Complex)
IBA
11/2002
1
Complementary DNA (cDNA)
IBA
03/2002
Therapy/Procedure
12
Therapeutics
01/2020 - 11/2002
11
Immunotherapy
10/2021 - 06/2005
3
Precision Medicine
04/2019 - 08/2015
1
Nephrectomy
08/2017